INS and adrenocortical insufficiency: The adverse effects observed in the DXM group may be attributed to the well-documented side effects of glucocorticoids, including suppression of the hypothalamic–pituitary–adrenal axis leading to adrenal cortical insufficiency, inhibition of gastrointestinal motility with reduced food intake, and disruption of energy metabolism through altered glucose and insulin regulation [31].